Table 5.
Cell line | Control | 24 h | 48 h | 24+24 | 24+48 |
Percentage of cells in S2 | |||||
VRL | |||||
ECV304 | 1.5 ± 0.2 | 5.5 ± 0.9a | 18.5 ± 1.2a * | 17.6 ± 2.3b | 20.1 ± 0.9b |
CAL-27 | 1.3 ± 0.1 | 5.6 ± 1.6 | 22.9 ± 1.5a | 12.3 ± 1.4b | 20.2 ± 0.9b |
MCF-7 | 2.2 ± 0.5 | 2.9 ± 0.8 | 9.7 ± 3.9 | 4.4 ± 0.6 | 8.6 ± 0.5b |
H292 | 1.4 ± 0.4 | 3.0 ± 1.0 | 7.9 ± 1.4a | 3.4 ± 0.7 | 5.7 ± 0.9 |
VFL | |||||
ECV304 | 1.3 ± 0.2 | 7.6 ± 1.3a | 22.4 ± 0.8a | 12.6 ± 1.1b | 16.2 ± 0.6b |
CAL-27 | 1.7 ± 0.5 | 4.3 ± 1.0 | 21.8 ± 1.4a | 11.8 ± 0.7 | 21.8 ± 0.8b |
MCF-7 | 2.0 ± 0.3 | 2.8 ± 1.0 | 8.8 ± 1.6a | 5.2 ± 0.4 | 10.6 ± 1.1b |
H292 | 1.0 ± 0.2 | 2.9 ± 0.5a | 7.1 ± 0.9a | 3.6 ± 1.2 | 4.5 ± 0.5 |
Percentage of cells in (G2/M)2 | |||||
VRL | |||||
ECV304 | 0.3 ± 0.0 | 1.2 ± 0.2a | 12.2 ± 1.5a | 9.8 ± 1.6b | 10.2 ± 1.3b |
CAL-27 | 0.4 ± 0.1 | 2.2 ± 0.6 | 37.4 ± 4.8a | 4.8 ± 0.5b | 6.1 ± 0.9b |
MCF-7 | 0.5 ± 0.1 | 1.3 ± 0.3 | 2.1 ± 0.5 | 2.1 ± 0.7 | 3.4 ± 0.2b |
H292 | 0.3 ± 0.1 | 1.1 ± 0.3 | 6.5 ± 1.0a | 1.4 ± 0.2 | 2.2 ± 0.2b |
VFL | |||||
ECV304 | 0.2 ± 0.0 | 0.8 ± 0.3 | 15.6 ± 0.8a | 8.5 ± 1.3b | 9.2 ± 1.1b |
CAL-27 | 0.3 ± 0.1 | 2.1 ± 0.5 | 41.8 ± 4.9a | 5.4 ± 0.4 | 7.5 ± 0.5b |
MCF-7 | 0.5 ± 0.1 | 1.3 ± 0.2a | 4.4 ± 0.8a | 2.0 ± 0.5 | 4.4 ± 0.4b |
H292 | 0.2 ± 0.0 | 1.2 ± 0.2a | 7.0 ± 0.9a | 1.9 ± 0.4 | 2.4 ± 0.3b |
Percentages of cells in the polyploid cell cycle: at different incubation times with VRL or VFL and at different times after drug removal; mean ± standard error.
a p < 0.05 compared to control
b p < 0.05 compared to 24 h incubation
* p < 0.05 compared to equitoxic VFL conc.